BMS mobilises research around immunotherapy

Wednesday 30 May 2012

Bristol-Myers Squibb Company is mobilising researchers at 10 different institutes in the US and Europe to investigate the role of immunotherapies in treating cancer. The project has been launched under the name ‘immuno-oncology network’.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United States